JP2024523822A5 - - Google Patents
Info
- Publication number
- JP2024523822A5 JP2024523822A5 JP2023574858A JP2023574858A JP2024523822A5 JP 2024523822 A5 JP2024523822 A5 JP 2024523822A5 JP 2023574858 A JP2023574858 A JP 2023574858A JP 2023574858 A JP2023574858 A JP 2023574858A JP 2024523822 A5 JP2024523822 A5 JP 2024523822A5
- Authority
- JP
- Japan
- Prior art keywords
- indole
- ethyl
- fluoro
- amine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195943P | 2021-06-02 | 2021-06-02 | |
| US63/195,943 | 2021-06-02 | ||
| US202163288313P | 2021-12-10 | 2021-12-10 | |
| US63/288,313 | 2021-12-10 | ||
| PCT/US2022/032000 WO2022256554A1 (en) | 2021-06-02 | 2022-06-02 | Fluorinated tryptamine compounds, analogues thereof, and methods using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523822A JP2024523822A (ja) | 2024-07-02 |
| JP2024523822A5 true JP2024523822A5 (cg-RX-API-DMAC7.html) | 2025-06-03 |
Family
ID=84324579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574858A Pending JP2024523822A (ja) | 2021-06-02 | 2022-06-02 | フッ素化トリプタミン化合物、その類似体、及びそれを使用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240286998A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4347559A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523822A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240017363A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022287013A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023025340A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3220850A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023018652A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308944A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014437A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022256554A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023002557A (es) * | 2020-09-01 | 2023-05-29 | Enveric Biosciences Canada Inc | Derivados de psilocibina halogenada y metodos de uso. |
| EP4396162A4 (en) | 2021-09-03 | 2025-11-12 | Alexander Shulgin Res Institute Inc | ASYMMETRIC ALLYL TRYPTAMINES |
| WO2023147424A1 (en) * | 2022-01-27 | 2023-08-03 | Terran Biosciences, Inc. | Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)- n-methylethan-1-amine |
| US12157722B1 (en) * | 2023-08-03 | 2024-12-03 | Gilgamesh Pharmaceuticals, Inc. | Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| US12129234B1 (en) | 2023-08-03 | 2024-10-29 | Gilgamesh Pharmaceuticals, Inc. | Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| CN121866243A (zh) * | 2023-09-07 | 2026-04-14 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 致幻化合物、其制备方法及其用途 |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0848706B1 (en) * | 1995-06-06 | 2003-02-05 | Schering Corporation | Substituted benzene-fused heterocyclics as neurokinin antagonists |
| DE19615232A1 (de) * | 1996-04-18 | 1997-10-23 | Merck Patent Gmbh | Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten |
| US6100291A (en) * | 1998-03-16 | 2000-08-08 | Allelix Biopharmaceuticals Inc. | Pyrrolidine-indole compounds having 5-HT6 affinity |
| AR021509A1 (es) * | 1998-12-08 | 2002-07-24 | Lundbeck & Co As H | Derivados de benzofurano, su preparacion y uso |
| US6800637B2 (en) * | 2002-09-12 | 2004-10-05 | Wyeth | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| JP7273731B2 (ja) * | 2017-02-09 | 2023-05-15 | カームテック、エルエルシー | シロシビン誘導体を含む組成物及び方法 |
| WO2019222552A1 (en) * | 2018-05-16 | 2019-11-21 | University Of Florida Research Foundation | Methods and compositions for substituted 2,5-diketopiperazine analogs |
| GB201907871D0 (en) * | 2019-06-03 | 2019-07-17 | Small Pharma Ltd | Therapeutic compositions |
| AU2021215709A1 (en) * | 2020-02-04 | 2022-09-01 | Mindset Pharma Inc. | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
| LT4084791T (lt) * | 2020-02-18 | 2025-02-25 | Gilgamesh Pharmaceuticals, Inc. | Specifiniai triptaminai, skirti nuotaikos sutrikimams gydyti |
| MX2023002557A (es) * | 2020-09-01 | 2023-05-29 | Enveric Biosciences Canada Inc | Derivados de psilocibina halogenada y metodos de uso. |
| CA3192617A1 (en) * | 2020-09-20 | 2022-03-24 | Matthew BAGGOTT | Advantageous tryptamine compositions for mental disorders or enhancement |
| US20240051978A1 (en) * | 2020-12-07 | 2024-02-15 | Mindset Pharma Inc. | 3-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disorders |
-
2022
- 2022-06-02 KR KR1020237044652A patent/KR20240017363A/ko active Pending
- 2022-06-02 MX MX2023014437A patent/MX2023014437A/es unknown
- 2022-06-02 CA CA3220850A patent/CA3220850A1/en active Pending
- 2022-06-02 AU AU2022287013A patent/AU2022287013A1/en active Pending
- 2022-06-02 EP EP22816868.8A patent/EP4347559A4/en active Pending
- 2022-06-02 IL IL308944A patent/IL308944A/en unknown
- 2022-06-02 US US18/565,565 patent/US20240286998A1/en active Pending
- 2022-06-02 WO PCT/US2022/032000 patent/WO2022256554A1/en not_active Ceased
- 2022-06-02 JP JP2023574858A patent/JP2024523822A/ja active Pending
- 2022-06-02 BR BR112023025340A patent/BR112023025340A2/pt unknown
-
2023
- 2023-12-29 CO CONC2023/0018652A patent/CO2023018652A2/es unknown